Leveraging the market demand for rapid biologics development, Esco Aster offers a strain development platform with state-of-the-art technology of random mutagenesis using Atmospheric Room Temperature Plasma (ARTP) technology and high-throughput and parallel screening of strains using Microbial Microdroplet Culture (MMC) system.
Combining these technologies, we can eliminate the limitations of conventional screening and save enormous time, labour, and cost.